Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Indazole-3-carboxylic acid | HCID 78250 | — |
| Reactant | P,P-Diphenylphosphinic azide | HCID 199401 | — |
| Reactant | HCID 10953883 | HCID 10953883 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 19921775 | HCID 19921775 | — |
Reaction Steps
In a 100-ml round-bottomed flask, 1.35 g (8.15 mmol) of 4-(5-methyl-1H-imidazol-4-yl)piperidine are placed in 15 ml of dichloromethane and 4 ml of dimethylformamide. 1.32 g (8.15 mmol) of 1H-indazole-3-carboxylic acid and 2.2 ml of triethylamine are added. The mixture is left stirring for 5 minutes. 3.5 ml of diphenylphosphoryl azide are added and the mixture is left stirring for 72 hours. Ethyl acetate is added and the mixture is extracted 3 times with 2N hydrochloric acid. The aqueous phase is recovered and alkalinized with sodium carbonate solution. It is extracted 3 times with ethyl acetate and the organic phase is collected, dried and evaporated to dryness. The residue is purified by chromatography on a column of silica gel, eluting with a dichloromethane/methanol/ammonia solution (90:10:1) mixture.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05434169 |
|---|
| Source dataset | uspto-grants-1995_07 |
|---|
| ORD ID | ord-dde07ab0a8454840b7ac8d583d3f0b2f |
|---|
| Source note | uspto-grants-1995_07 |
|---|